Auto Immune Markers in Type 1 Diabetes and Thyroid Dysfunction in Egyptian Patients
Abdel Monem, A., Ziada, A., Mahmoud, E. (2019). Auto Immune Markers in Type 1 Diabetes and Thyroid Dysfunction in Egyptian Patients. EKB Journal Management System, 28(1), 73-79. doi: 10.21608/ejmm.2019.282406
Abeer Ahmed Abdel Monem; Adel A. Ziada; Eman Mahmoud. "Auto Immune Markers in Type 1 Diabetes and Thyroid Dysfunction in Egyptian Patients". EKB Journal Management System, 28, 1, 2019, 73-79. doi: 10.21608/ejmm.2019.282406
Abdel Monem, A., Ziada, A., Mahmoud, E. (2019). 'Auto Immune Markers in Type 1 Diabetes and Thyroid Dysfunction in Egyptian Patients', EKB Journal Management System, 28(1), pp. 73-79. doi: 10.21608/ejmm.2019.282406
Abdel Monem, A., Ziada, A., Mahmoud, E. Auto Immune Markers in Type 1 Diabetes and Thyroid Dysfunction in Egyptian Patients. EKB Journal Management System, 2019; 28(1): 73-79. doi: 10.21608/ejmm.2019.282406

Auto Immune Markers in Type 1 Diabetes and Thyroid Dysfunction in Egyptian Patients

Egyptian Journal of Medical Microbiology
Article 10, Volume 28, Issue 1, January 2019, Page 73-79  XML PDF (454 K)
Document Type: New and original researches in the field of Microbiology.
DOI: 10.21608/ejmm.2019.282406
View on SCiNiTO View on SCiNiTO
Authors
Abeer Ahmed Abdel Monem email 1; Adel A. Ziada2; Eman Mahmoud3
1Department of Medical Microbiology& Immunology, Faculty of Medicine – Beni-Suef University
2Department of Clinical Pathology, Faculty of medicine, Al-Azhar University
3Department of Endocrinology and metabolism, Faculty of medicine for Girls, Al-Azhar University
Abstract
Background: Type 1 diabetes mellitus (T1DM) is a common endocrine disorder associated with aberrant immune responses to specific β-cell auto-antigens. Markers of the process are various including auto-antibodies to glutamic acid decarboxylase (GADA) and to islet cell (IA-2). Other autoimmune diseases such as thyroid dysfunction are more common in T1DM. Autoimmune thyroid diseases are the most prevalent immunological diseases in patients with type 1 diabetes. Objectives: This study was planned to clarify the occurrence of autoimmune thyroid dysfunction and auto-antibodies in Egyptian patients with T1DM in patients without any history of thyroid disease and to assess its relation with diabetes-specific auto-antibodies. Methodology: This is a prospective case-controlled clinically-based study. Sixty patients diagnosed with diabetes type 1 according to WHO criteria for diagnosis of diabetes mellitus (DM) and 30 healthy controls matched for age, sex and body mass index (BMI) were recruited from the outpatient clinic of Endocrinology Department, Al-Zahraa Hospital, Al-Azhar University. All patients and controls were subjected to; Random blood glucose level, Glycated Hemoglobin (Hb A1c) assay level, Anti glutamic acid decarboxylase (anti-GAD), C-peptide level and Anti islet cell antigen (IA-2) auto antibodies, Serum free T3, free T4, TSH and Anti-Thyroid Autoantibodies (antithyoid peroxidase- TPO and anti-thyroglobulin-TG) were also done. Results: We reported that 45 patients (75.0%) were positive to autoantibody for GAD, 17 patients (28.3%) were positive for IA-2, 15 patients (25.0 %) for TPO, and 10 patients (16.66 %) were positive for TG-AB. All subjects with overt hypothyroidism (5 patients / 8.33%) had positive GAD and thyroid auto-antibodies, subclinical hypothyroidism (SCH) were reported in 15 patients (25%) and One subject only (1.67%) had clinical hyperthyroidism. Conclusions: We found a high prevalence of diabetes-specific auto-antibodies in T1DM patients. Subclinical thyroid dysfunction was evident in a considerable number of T1DM patients. These results indicate the importance of regular thyroid screening in T1DM patients.
Keywords
Thyroid dysfunction; anti-glutamic acid decarboxylase antibody; Anti islet cell (IA-2) auto-antibodies; Thyroid Auto-antibodies; type 1 diabetes mellitus (T1DM)
Statistics
Article View: 54
PDF Download: 48